Bayer Lacks Standing To Dispute 'Flanax' Trademark

Law360, Los Angeles (February 6, 2015, 8:24 PM EST) -- Bayer AG doesn’t have standing to bring a trademark proceeding against a small drug company using the name “Flanax” for painkillers it sells in the U.S. because Bayer calls the drug "Aleve" in the U.S., a Virginia federal judge ruled Friday.

U.S. District Judge Gerald Bruce Lee reversed the Trademark Trial and Appeal Board’s April decision canceling drugmaker Belmora LLC’s registration for Flanax, which it used to brand naproxen sodium-based bills and other products, according to the decision. Judge Lee found that Bayer didn’t have standing to bring the claim because it doesn’t hold a mark for Flanax in the U.S.,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Virginia Eastern

Nature of Suit

Trademark

Judge

Subscribers Only

Date Filed

July 8, 2014

Law Firms

Companies

Government Agencies